August 12, 2025British Journal of DermatologyOpen Access

EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders

View Full Paper

Ask AI

Bookmark

Authors

RWRein WillemzeLeiden University Medical Center CAChalid AssafMSH Medical School Hamburg – University of Applied Sciences and Medical University MBM. BagotUniversité Paris Cité

Discussion

Member takes

Implication

Consensus recommendations emphasize uniform treatment and follow-up strategies in cutaneous lymphoproliferative disorders, suggesting low-dose radiotherapy and corticosteroids.

Key Points

Key recommendations call for low-dose radiotherapy for treating primary cutaneous lymphoproliferative disorders, enhancing treatment efficacy.
Staging examinations are minimized for typical cases of primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder, reducing patient burden.
Surveys among 30 expert centers informed the recommendations, indicating the importance of consensus in clinical management of these disorders.
These consensus recommendations aim to standardize treatment and follow-up policies across cutaneous lymphoma centers, improving patient care.

Cite This Study

Willemze et al. (2025) studied this question.

synapsesocial.com/papers/68c23595b210217d64771576 https://doi.org/10.1093/bjd/ljaf312

View Full Paper

Ask AI

Bookmark

Implication

Consensus recommendations emphasize uniform treatment and follow-up strategies in cutaneous lymphoproliferative disorders, suggesting low-dose radiotherapy and corticosteroids.